Ancora Heart Raises $80M To Support Ongoing Trial To Treat Heart Failure Patients

 
• By Marion Webb

Ancora Heart will use the new funding to accelerate its pivotal trial of the AccuCinch ventricular restoration system for treating heart failure patients with reduced ejection fraction.

Heartfailure

More from Cardiology

More from Device Area